A "Watchful Surgery" Approach: Timing and Valve Choice for Mildly Symptomatic Mitral and Aortic Valve Disease.

Journal of surgery and research Pub Date : 2025-01-01 Epub Date: 2025-09-22 DOI:10.26502/jsr.10020472
Shaanali Mukadam, Chang Kon Kim, Devendra K Agrawal
{"title":"A \"Watchful Surgery\" Approach: Timing and Valve Choice for Mildly Symptomatic Mitral and Aortic Valve Disease.","authors":"Shaanali Mukadam, Chang Kon Kim, Devendra K Agrawal","doi":"10.26502/jsr.10020472","DOIUrl":null,"url":null,"abstract":"<p><p>The timing of surgical intervention and prosthesis selection in mildly symptomatic aortic and mitral valve disease remain an area of clinical uncertainty. Symptom-based referral often occurs after the onset of adverse ventricular remodeling, whereas earlier surgery may improve long-term outcomes but introduces procedural risk. This article synthesized contemporary evidence to delineate optimal strategies in this intermediate-risk population. In aortic stenosis, randomized trials including RECOVERY and AVATAR demonstrate that early surgical aortic valve replacement reduces heart failure events and may improve survival. In aortic and mitral regurgitation, observational data associate early intervention, triggered by mild symptoms or subclinical ventricular dysfunction, with improved survival and preservation of cardiac function. Emerging modalities such as global longitudinal strain and natriuretic peptide biomarkers enhance risk stratification in asymptomatic individuals. Prosthesis selection is primarily informed by patient age, comorbidity burden, and anticoagulation tolerance. Mechanical valves confer superior durability and lower reoperation risk in younger patients. Bioprosthetic valves are increasingly favored in older adults due to compatibility with transcatheter valve-in-valve reintervention and avoidance of lifelong anticoagulation. Comparative cohort studies and meta-analyses suggest a survival benefit for mechanical valves up to approximately 65-to-70 years of age, beyond which the benefit diminishes due to competing mortality risks. Evidence supports timely surgical referral in mildly symptomatic patients, particularly in the presence of early imaging or biomarker evidence of ventricular dysfunction. Individualized decision-making through multidisciplinary heart team evaluation remains essential. Further investigations are warranted to define long-term prosthetic durability and the role of early surgery in valvular regurgitation.</p>","PeriodicalId":73961,"journal":{"name":"Journal of surgery and research","volume":"8 3","pages":"460-476"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12674204/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of surgery and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/jsr.10020472","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/22 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The timing of surgical intervention and prosthesis selection in mildly symptomatic aortic and mitral valve disease remain an area of clinical uncertainty. Symptom-based referral often occurs after the onset of adverse ventricular remodeling, whereas earlier surgery may improve long-term outcomes but introduces procedural risk. This article synthesized contemporary evidence to delineate optimal strategies in this intermediate-risk population. In aortic stenosis, randomized trials including RECOVERY and AVATAR demonstrate that early surgical aortic valve replacement reduces heart failure events and may improve survival. In aortic and mitral regurgitation, observational data associate early intervention, triggered by mild symptoms or subclinical ventricular dysfunction, with improved survival and preservation of cardiac function. Emerging modalities such as global longitudinal strain and natriuretic peptide biomarkers enhance risk stratification in asymptomatic individuals. Prosthesis selection is primarily informed by patient age, comorbidity burden, and anticoagulation tolerance. Mechanical valves confer superior durability and lower reoperation risk in younger patients. Bioprosthetic valves are increasingly favored in older adults due to compatibility with transcatheter valve-in-valve reintervention and avoidance of lifelong anticoagulation. Comparative cohort studies and meta-analyses suggest a survival benefit for mechanical valves up to approximately 65-to-70 years of age, beyond which the benefit diminishes due to competing mortality risks. Evidence supports timely surgical referral in mildly symptomatic patients, particularly in the presence of early imaging or biomarker evidence of ventricular dysfunction. Individualized decision-making through multidisciplinary heart team evaluation remains essential. Further investigations are warranted to define long-term prosthetic durability and the role of early surgery in valvular regurgitation.

Abstract Image

Abstract Image

Abstract Image

“谨慎手术”方法:轻度症状二尖瓣和主动脉瓣疾病的时机和瓣膜选择。
轻度症状主动脉瓣和二尖瓣疾病的手术干预时机和假体选择仍然是临床不确定的领域。基于症状的转诊通常发生在不良心室重构发生后,而早期手术可能改善长期预后,但会带来手术风险。本文综合了当代证据来描述这种中等风险人群的最佳策略。在主动脉瓣狭窄中,包括RECOVERY和AVATAR在内的随机试验表明,早期手术主动脉瓣置换术可减少心力衰竭事件,并可能提高生存率。在主动脉瓣和二尖瓣反流中,观察数据表明,由轻微症状或亚临床心室功能障碍引发的早期干预可以改善生存和保存心功能。新兴模式,如全球纵向应变和利钠肽生物标志物增强无症状个体的风险分层。假体的选择主要取决于患者的年龄、合并症负担和抗凝耐受性。机械瓣膜在年轻患者中具有较好的耐用性和较低的再手术风险。生物瓣膜在老年人中越来越受青睐,因为它与经导管瓣内再介入手术兼容,并且避免了终身抗凝。比较队列研究和荟萃分析表明,机械瓣膜的生存益处可达65- 70岁,超过65- 70岁后,由于竞争的死亡风险,获益减少。证据支持对症状轻微的患者及时进行手术转诊,特别是在存在早期影像学或生物标志物证据的心室功能障碍的情况下。通过多学科心脏团队评估进行个性化决策仍然至关重要。需要进一步的研究来确定假体的长期耐久性和早期手术在瓣膜反流中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书